ATRA vs HUBS · rev $1.1M vs P/E 96, rev $1.79B
Atara Biotherapeutics Inc (ATRA) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported ATRA revenue for 2026-06-30 was $1.1M. Net income was -$9.0M. ATRA currently screens at market cap $87.1M.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
ATRA currently screens at market cap $87.1M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the ATRA and HUBS stock pages for the full models.
Not investment advice.